Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Positively charged water-soluble prodrugs of ibuprofen with very fast skin penetration rate

A technology for transdermal drug delivery and active ingredients, applied in the field of water-soluble prodrugs

Active Publication Date: 2009-07-22
江苏昕晨泰飞尔医药科技有限公司
View PDF11 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, it is difficult to achieve therapeutically effective plasma concentrations of ibuprofen by formulation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Positively charged water-soluble prodrugs of ibuprofen with very fast skin penetration rate
  • Positively charged water-soluble prodrugs of ibuprofen with very fast skin penetration rate
  • Positively charged water-soluble prodrugs of ibuprofen with very fast skin penetration rate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment approach

[0060] Synthesis of dimethylaminoethyl 2-(p-isobutylphenyl)propionate acetate

[0061] 22.5g (0.1mol) of 2-(p-isobutylphenyl)propionyl chloride was dissolved in 100ml of chloroform. The mixture was cooled to 0 °C. 15 ml of triethylamine and 8.9 g of dimethylaminoethanol were added. The mixture was stirred at room temperature for 3 hours. 6 g of acetic acid was added to the reaction mixture with stirring. The solid by-product was removed by filtration and washed three times with 30 mL of chloroform. The organic phase was evaporated. After drying, 31 g of the hygroscopic target product was obtained with a yield of 92%. Solubility in water: 400mg / ml; Elemental analysis: C 19 h 31 NO 4 ;Molecular weight: 337.45. Theoretical %C: 67.63; H: 9.26; N: 4.15; O: 18.96; found %C: 67.60; H: 7.28; N: 4.14; O: 18.98. 1 H-NMR (400MHz, deuterated chloroform solvent): δ: 1.01(d, 6H), 1.52(d, 3H), 2.21(s, 3H), 2.22(m, 1H); 2.51(d, 2H), 2.90 (s, 6H), 3.52 (m, 2H), 3.78 (m, 1H), 4.52 (t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The novel positively charged pro-drugs of ibuprofen in the general formula (I) ''Structure 1'' were designed and synthesized. The compounds of the general formula (I) ''Structure 1'' indicated above can be prepared from functional derivatives of ibuprofen, (for example acid halides or mixed anhydrides), by reaction with suitable alcohols, thiols, or amines. The positively charged amino groups of these pro-drugs not only largely increases the solubility of the drugs, but also bonds to the negative charge on the phosphate head group of membranes and pushes the pro-drug into the cytosol. The experiment results suggest that the pro-drug, diethylaminoethyl 2-(p-isobutylphenyl) propionate.AcOH, diffuses through human skin -250 times faster than ibuprofen itself and -125 times faster than ethyl 2-(p-isobutylphenyl) propionate. In plasma, more than 90% of these pro-drugs can change back to the drug in a few minutes. The prodrugs can be used medicinally in treating any ibuprofen-treatable conditions in humans or animals and be administered not only orally, but also transdermally for any kind of medical treatments and avoid most of the side effects of ibuprofen, most notably GI disturbances such as dyspepsia, gastroduodenal bleeding, gastric ulcerations, and gastritis. Controlled transdermal administration systems of the prodrug enable the ibuprofen to reach constantly optimal therapeutic blood levels to increase effectiveness and reduce the side effects of ibuprofen.

Description

technical field [0001] The present invention relates to positively charged water-soluble prodrugs of 2-(p-isobutylphenyl)propionic acid (ibuprofen) and their medical use in the treatment of any ibuprofen-treatable condition in humans or animals . Specifically, the present invention is to overcome the side effects brought by the use of ibuprofen. These prodrugs can be administered orally or transdermally. technical background [0002] Ibuprofen is a propionate NSAID. Ibuprofen was synthesized for the first time in 1964 (J.S.Nicholson and S.S.Adams, Br.Patent No.971,700) and was first used as a medicine in Europe. Ibuprofen was more effective than aspirin in anti-inflammatory and inhibition of prostaglandin biosynthesis experiments. "PDR Generics" (PDR Generics, 1996, second edition, Medical Economics, Montvale, New Jersey, pg 243) lists the various medical uses of ibuprofen. Ibuprofen can be used to relieve the symptoms of rheumatoid arthritis and osteoarthritis, reduce ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07C211/63
CPCC07C327/30C07C211/63C07C233/40A61P11/06A61P15/00A61P17/00A61P17/10A61P19/02A61P25/04A61P25/06A61P27/02A61P27/06A61P27/14A61P27/16A61P29/00A61P35/00A61P43/00
Inventor 于崇曦徐丽娜
Owner 江苏昕晨泰飞尔医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com